1 | http://www.hhs.gov/
| Whois | hhs.gov |
2 | https://medicalcountermeasures.gov/barda/core-services/ciadm.aspx
| Whois | . |
3 | https://mrc.hhs.gov/HomePage
| Whois | . |
4 | https://asprtracie.hhs.gov/
| Whois | . |
5 | https://empowermap.hhs.gov/
| Whois | . |
6 | http://geohealth.hhs.gov/arcgis/home/
| Whois | . |
7 | https://nowtrending.hhs.gov/
| Whois | . |
8 | http://chemm.nlm.nih.gov/index.html
| Whois | . |
9 | http://www.remm.nlm.gov/index.html
| Whois | . |
10 | http://wiser.nlm.nih.gov/
| Whois | . |
11 | http://emergency.cdc.gov/disasters/psa/
| Whois | . |
12 | https://www.hhs.gov/sites/default/files/fy-2022-phssef-cj.pdf
| Whois | . |
13 | https://medicalcountermeasures.gov/barda/core-services.aspx
| Whois | . |
14 | https://drive.hhs.gov/partner.html?id=applyNow
| Whois | . |
15 | https://carb-x.org/
| Whois | . |
16 | https://www.medicalcountermeasures.gov/barda/barda-baa
| Whois | . |
17 | https://beta.sam.gov/
| Whois | . |
18 | https://www.grants.gov/web/grants/search-grants.html?agencyCode=HHS-OS-ASPR
| Whois | . |
19 | https://drive.hhs.gov/partner.html?id=applyNow
| Whois | . |
20 | https://www.usphs.gov/apply/apply.aspx
| Whois | . |
21 | https://www.hhs.gov/about/agencies/orgchart/aspr/index.html
| Whois | . |
22 | https://cloud.connect.hhs.gov/PHE
| Whois | . |
23 | https://twitter.com/asprgov
| Whois | . |
24 | https://www.facebook.com/asprgov
| Whois | . |
25 | https://www.flickr.com/photos/asprgov
| Whois | . |
26 | https://www.youtube.com/c/ASPRgov
| Whois | . |
27 | https://www.linkedin.com/showcase/hhs-aspr
| Whois | . |
28 | https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure
| Whois | . |
29 | https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19-certain
| Whois | fda.gov |
30 | https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19
| Whois | fda.gov |
31 | https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure
| Whois | fda.gov |
32 | https://www.fda.gov/news-events/press-announcements/fda-expands-authorization-two-monoclonal-antibodies-treatment-and-post-exposure-prevention-covid-19
| Whois | fda.gov |
33 | https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19-certain
| Whois | fda.gov |
34 | https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19
| Whois | fda.gov |
35 | https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure
| Whois | fda.gov |
36 | https://www.fda.gov/news-events/press-announcements/fda-expands-authorization-two-monoclonal-antibodies-treatment-and-post-exposure-prevention-covid-19
| Whois | fda.gov |
37 | https://medicalcountermeasures.gov/app/barda/coronavirus/COVID19.aspx
| Whois | . |
38 | https://medicalcountermeasures.gov/barda/barda-covid-19-response/
| Whois | . |
39 | https://twitter.com/asprgov
| Whois | . |
40 | https://www.facebook.com/asprgov
| Whois | . |
41 | https://www.instagram.com/asprgov/
| Whois | . |
42 | http://www.hhs.gov/plugins.html
| Whois | hhs.gov |
43 | http://www.hhs.gov/open/plain-writing/index.html
| Whois | hhs.gov |
44 | http://www.hhs.gov/
| Whois | hhs.gov |
45 | http://www.usa.gov/
| Whois | usa.gov |
46 | http://www.usa.gov/gobiernousa/
| Whois | usa.gov |
47 | https://www.healthcare.gov/
| Whois | healthcare.gov |
48 | https://www.healthcare.gov/language-resource
| Whois | healthcare.gov |